Brigatinib for ALK-positive metastatic non-small-cell lung cancer: design, development and place in therapy

por Ali, Robert, Arshad, Junaid, Palacio, Sofia, Mudad, Raja
Publicado 2019

Dataset used in the economic evaluation trastuzumab-based regimens for HER-2 positive metastatic breast cancer patients in the Taiwanese healthcare setting

por Diaby, Vakaramoko, Wang, Ching-Yu, Alqhtani, Hussain, van Boemmel-Wegmann, Sascha, Ali, Askal Ayalew, Balkrishnan, Rajesh, Ko, Yu, Palacio, Sofia, de Lima Lopes, Gilberto
Publicado 2020

A cost-effectiveness analysis of trastuzumab-containing treatment sequences for HER-2 positive metastatic breast cancer patients in Taiwan

por Diaby, Vakaramoko, Alqhtani, Hussain, van Boemmel-Wegmann, Sascha, Wang, Ching-Yu, Ali, Askal Ayalew, Balkrishnan, Rajesh, Ko, Yu, Palacio, Sofia, de Lima Lopes, Gilberto
Publicado 2019